Novo Nordisk shares plunge amid lower 2026 sales outlook
Go back to Novo Nordisk shares plunge amid lower 2026 sales outlook| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1215.02 -16.92 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1231.94 | 52 Week High | $88.16 | |||
| Open | $1230.65 | 52 Week Low | $67.88 | |||
| Day High | $1238.00 | P/E | 281.25 | |||
| Day Low | $1209.53 | EPS | $4.32 | |||
| Volume | 2,113,569 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 47.17 -0.56 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.73 | 52 Week High | $59.00 | |||
| Open | $47.45 | 52 Week Low | $32.80 | |||
| Day High | $47.67 | P/E | N/A | |||
| Day Low | $46.93 | EPS | $0.00 | |||
| Volume | 7,834,033 | |||||
